If the merger of Pfizer’s off-patent drug unit and Mylan is approved, Mylan CEO Heather Bresch could earn more than $37.6 million in severance and vested benefits, according to The Pittsburgh Post ...

WASHINGTON — Despite a withering 4-plus hours of questioning by members of a congressional committee yesterday, Mylan CEO Heather Bresch did not give a direct answer as to why the company had ...

Outraged Republican and Democratic lawmakers on Wednesday grilled the head of pharmaceutical company Mylan about the significant cost increase of its life-saving EpiPens and the profits for a company ...

Heather Bresch will face the proverbial lash from Congress on Wednesday over the escalating cost of Mylan NV’s EpiPen. Her boss won’t. Robert J. Coury acquired the rights to sell the emergency allergy ...

Mylan will make its generic to EpiPen available for purchase next week, according to npr. 1. The generic will cost half as much as EpiPen, carrying a list price of $300 for a two-pack. 2. In a ...

The controversy surrounding the cost of EpiPen’s did not stop Fortune from including Mylan CEO Heather Bresch on its “Most Powerful Women” list for 2016. Ms. Bresch faced large backlash in the past ...

Since pharmaceutical company Mylan acquired and began selling EpiPen nearly 10 years ago, the drug’s price has spiked almost 400 percent, leading the company’s CEO to come under intense scrutiny, ...

Drugmaker Mylan will pay $465 million to settle allegations that it overbilled Medicaid for its life-saving EpiPen, ending one of the controversies over the soaring price of the emergency allergy ...

NEW YORK, Aug 6 (Reuters) - Generic drugmaker Mylan Inc 's Chief Executive Heather Bresch said Thursday acquiring Perrigo Co was not a must and it had other options besides Perrigo, which has rejected ...

The company's CEO will defend her company's increase in EpiPen pricing. — -- Mylan Pharmaceuticals CEO Heather Bresch is expected to defend her company’s increase in EpiPen pricing when she ...

Mylan Inc. CEO Heather Bresch. In August, Mylan NV CEO Heather Bresch said that the Canonsburg-based company had its sights on acquisitions, despite its impending failure to take over Perrigo Co. plc.